By Paul Sandle LONDON (Reuters) -Britain’s antitrust regulator said on Friday it had provisionally found Alphabet (NASDAQ:GOOGL)’s Google had abused its dominant position
By Maria Martinez and John O’Donnell BERLIN (Reuters) – Having lost cheap energy from Russia and facing uncertainty over its once-lucrative trade ties
Zenas BioPharma (ZBIO) has filed for 11,760,000 share IPO at $16-$18 per share. This post appeared first on investing.com
(Reuters) -Star Entertainment will sell its interest in the Treasury Brisbane Casino building in Queensland for A$67.5 million ($45.47 million), the embattled
By Steven Scheer JERUSALEM (Reuters) – Israel’s ultra-Orthodox parties, already at odds with coalition partners over demands to draft young religious men into
(Reuters) – The volatile activity that has marked September so far may not let up any time soon, as investors are on
Investing.com — The calm following early August’s volatility and unwinding may soon come to an end with Friday’s much-anticipated nonfarm payrolls (NFP)
Investing.com — Stock futures on Wall Street edge lower ahead of the publication of this week’s all-important labor market report, which could influence
Investing.com — Shares of Elis (EPA:ELIS) slumped by 16% on Friday following a Reuters report that the French workplace supplies company had
(Reuters) -Shares in Elis tumbled 16% on Friday after Reuters reported, citing sources, that the French workplace supplies provider had approached Vestis,
